Establishment of human dedifferentiated fat (DFAT) cells preparation method and DFAT cell-based therapies
Not Applicable
- Conditions
- ormal healthy subjects
- Registration Number
- JPRN-UMIN000027905
- Lead Sponsor
- ihon University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Positive for the following laboratory test results: serological test for syphilis, HBs antigen, HCV antibody, and HIV antibody. (2) Current active infection or diagnosed with severe infectious diseases within the last 3 months. (3) Current use of anticoagulation medications that affect bleeding. (4) Subjects with history of drug or alcohol dependence. (5) Current use of systemic steroids or immunosuppressive agents (6) Pregnant woman, lactating mother, or woman who is suspected pregnancy. (7) Any other medical reasons judged by the doctor-in-charge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Preparation of the good manufacturing practice-compliant production of DFAT cells
- Secondary Outcome Measures
Name Time Method Therapeutic potential and transplantation safety of DFAT cells will be assessed by animal experiments